While painful (for most folks) to watch, the actor’s explosion has created a bonanza for the tabloid mill. But on a broader level, Sheen has also offers a potential shot in the arm for companies across the spectrum, from media …
While painful (for most folks) to watch, the actor’s explosion has created a bonanza for the tabloid mill. But on a broader level, Sheen has also offers a potential shot in the arm for companies across the spectrum, from media …
The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimate…
Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What’s ahead …
Diabetes is a growing global scourge, but for Big Pharma it’s more of a lifesaver — and many drugmakers are cranking up their research efforts. After all, many existing drugs will soon be losing their patents, and diabetes cou…